Call (704)-333-7376 Are You a New Patient/Provider?
Click Here Are You a Current Patient/Provider?

About Our Doctors

You are here: Home / About Our Doctors / John B. Konefal, MD
John B. Konefal, MD | SERO Doctors | Lake Norman Radiation Oncology, NC

John B. Konefal, MD

Radiation Oncologist

"I was impressed with the rapidly evolving technology and potential of radiation in curing, extending the lives, and improving the quality of life of cancer patients."

- Dr. Konefal

New Patients/Providers:
(704) 380-0730

Hospital AffiliationsLake Norman Radiation Oncology

About

I am currently the Medical Director of Lake Norman Radiation Oncology Center, and enjoy living in the community where I work. While I treat all cancers, I have a particular interest and expertise in treating prostate cancer with brachytherapy - the placement of radioactive seeds within the prostate. When I'm not in the office, I spend time with my wife and three daughters, and enjoy golfing, skiing, reading and traveling.

Board Certification

June 8, 1989

Licensure

North Carolina #33538

South Carolina #14252

Professional Organizations

Education

Undergraduate

1976 — 1980

Colgate University
Hamilton, New York
B. A. (Combined Majors: Physics, Chemistry, Math)

Medical School

1980 — 1984

University of Vermont College of Medicine
Burlington, Vermont
M.D. (Major - Internal Medicine)

Residency

1984 — 1985

University of Kentucky Medical Center
Lexington, Kentucky
(Internal Medicine)

Residency

1985 — 1989

Mallinckrodt Institute of Radiology
Washington University Medical Center
St. Louis, Missouri (Radiation Oncology)

Employment

SERO

—

Charlotte, NC

- Publications

“Malignant Melanoma: Analysis of Dose Fractionation in Radiation Therapy.” Radiology. September 1987; Vol. 164:607- 610.
“Radiation Therapy in the Treatment of Chemodectomas.” Laryngoscope. November 1987; Vol. 97. No.11:1331-1335.
Analysis of Dose Fractionation in the Palliation of Metastases from Malignant Melanoma.” Cancer. January 15, 1988; Vol. 61,
No. 2:243-246.
“Radiation Therapy in Chemodectoma Treatment (letter to the editor).” Laryngoscope. April 1988; Vol. 98, No. 4:465-466.
“The Effects of Altered Fractionation Schedules on the Survival of Human Cell Lines Differing in Their Proliferative Activity and Repair Capacity.” International Journal of Radiation Oncology, Biology and Physics. 1990 Vol. 17, pp. 1007 – 1013.

“Thermoradiotherapy of Malignant Melanoma.” International Journal of Hyperthermia. 1988, Vol. 4, No. 4:373 – 381.
“Endocavitary Radiation for Rectal Carcinoma: Results with and without External Beam.” Endocurietherapy/Hyperthermia Oncology. 1989; 5:195-200.

+ Selected Meeting Presentations

“Radiation Therapy of Malignant Melanoma: Analysis of Dose Fractionation.” The Radiological Society of North America, 73rd Scientific Assembly and Annual Meeting. December 3, 1987

“Endocavitary Radiation for Early Rectal Carcinomas: The Experience at Washington University.” American Society Therapeutic Radiology and Oncology, 29th Annual Meeting. October 23, 1987
“The Effects of Altered Fractionation Schedules on the Survival of Human Cell Lines Differing in their Proliferative Activity and Repair Capacity.” American Society Therapeutic Radiology and Oncology, 30th Annual Meeting. October 10, 1988

Comments are closed.

Jeffrey G. Kuremsky, MD Jeffrey G. Kuremsky, MD | SERO Doctors | Lancaster Radiation Therapy Center, NC Lauren Jones Lauren Jones, PA